We are live on ! Find out more
TXG icon

10x Genomics
TXG

254 hedge funds and large institutions have $3.91B invested in 10x Genomics in 2022 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 96 increasing their positions, 85 reducing their positions, and 92 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more repeat investments, than reductions

Existing positions increased: 96 | Existing positions reduced: 85

2.91% more ownership

Funds ownership: 88.75% → 91.66% (+2.9%)

0% more funds holding in top 10

Funds holding in top 10: 8 → 8 (0)

19% less funds holding

Funds holding: 314 → 254 (-60)

34% less call options, than puts

Call options by funds: $13.9M | Put options by funds: $21.1M

38% less capital invested

Capital invested by funds: $6.29B → $3.91B (-$2.38B)

61% less first-time investments, than exits

New positions opened: 36 | Existing positions closed: 92

Holders
254
Holders Change
-60
Holders Change %
-19.11%
% of All Funds
4.28%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
36
Increased
96
Reduced
85
Closed
92
Calls
$13.9M
Puts
$21.1M
Net Calls
-$7.23M
Net Calls Change
+$3.98M

Top Buyers

1
GIM
Generation Investment Management
United Kingdom
+$136M
2
SIM
SRS Investment Management
New York
+$132M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$107M
4
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$53.1M
5
JP Morgan Chase
JP Morgan Chase
New York
+$48.1M

Top Sellers

1
BlackRock
BlackRock
New York
-$121M
2
Ameriprise
Ameriprise
Minnesota
-$81.9M
3
1WCM
12 West Capital Management
New York
-$65.8M
4
Allspring Global Investments
Allspring Global Investments
North Carolina
-$55.1M
5
FAM
Fred Alger Management
New York
-$25M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$403M -$21M -404,980 -4%
Baillie Gifford & Co
2
Baillie Gifford & Co
United Kingdom
$379M +$53.1M +1,023,207 +14%
Vanguard Group
3
Vanguard Group
Pennsylvania
$354M +$4.94M +95,235 +1%
BlackRock
4
BlackRock
New York
$309M -$121M -2,334,744 -25%
Fidelity Investments
5
Fidelity Investments
Massachusetts
$280M +$107M +2,070,318 +50%
AIM
6
ARK Investment Management
Florida
$184M +$11M +211,948 +6%
Sands Capital Management
7
Sands Capital Management
Virginia
$160M +$16.9M +325,484 +10%
SIM
8
SRS Investment Management
New York
$125M +$132M +2,548,380 +1,214%
GIM
9
Generation Investment Management
United Kingdom
$119M +$136M +2,623,190 New
BCM
10
Brown Capital Management
Maryland
$110M +$39.8M +767,486 +46%
FCMI
11
Foresite Capital Management II
California
$79.3M – – –
CS
12
Credit Suisse
Switzerland
$76.3M +$16.1M +311,027 +23%
Sumitomo Mitsui Trust Group
13
Sumitomo Mitsui Trust Group
Japan
$64M -$10.6M -204,514 -13%
T. Rowe Price Associates
14
T. Rowe Price Associates
Maryland
$60.6M +$9.75M +187,833 +16%
State Street
15
State Street
Massachusetts
$60.5M -$17.9M -345,543 -21%
NAMA
16
Nikko Asset Management Americas
New York
$56.6M -$930K -17,934 -1%
1WCM
17
12 West Capital Management
New York
$56.5M -$65.8M -1,268,854 -50%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$55.2M +$1.61M +31,078 +3%
MCAV
19
Meritech Capital Associates V
California
$48M -$14.2M -274,571 -21%
JP Morgan Chase
20
JP Morgan Chase
New York
$45.7M +$48.1M +926,161 +1,106%
ClearBridge Investments
21
ClearBridge Investments
New York
$43.5M -$24.9M -480,225 -33%
RI
22
RTW Investments
New York
$43.4M +$11.7M +225,000 +31%
Capital World Investors
23
Capital World Investors
California
$39.2M +$45M +866,700 New
Bank of New York Mellon
24
Bank of New York Mellon
New York
$37.6M -$215K -4,140 -0.5%
Franklin Resources
25
Franklin Resources
California
$36.3M +$6.08M +117,264 +17%
1
2 3 4 5

TXG Hedge Fund Activity: Q2 2022 in Review

254 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in 10x Genomics (TXG) for Q2 2022, worth a combined $3.91B — down 38% from $6.29B a quarter earlier.

Sellers outnumbered buyers: 92 funds closed out of TXG and 36 opened new positions — a net loss of 56 holders — while 85 trimmed existing stakes and 96 added.

The largest buyer was Generation Investment Management, opening a new position worth an estimated $136M. The largest seller was BlackRock, cutting an estimated $121M.

  • 254 institutional investors held 10x Genomics (TXG) as of Q2 2022, down from 314 in Q1 2022.
  • Funds reported $3.91B of 10x Genomics stock for Q2 2022, down 38% quarter-over-quarter.
  • 36 funds opened new 10x Genomics positions in Q2 2022 and 92 closed out, a net change of -56 holders.
  • The largest 10x Genomics buyer in Q2 2022 was Generation Investment Management, an estimated $136M added.
  • The largest 10x Genomics seller in Q2 2022 was BlackRock, an estimated $121M sold.

Based on aggregated 13F filings for Q2 2022.